SCHEMBL4342113

SCHEMBL4342113

Cc1cn(OP(=O)(O)O)c(=O)[nH]c1=O

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TYMP P19971 4/20 0.49
▸ MAPK1 P28482 1/20 0.41
▸ TK1 P04183 3/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28575356 0.98 TYMP (0.48) TYMPMAPK1TK1HPGD
SCHEMBL6911384 0.88 TYMP (0.44) TYMPMAPK1TK1HPGD
SCHEMBL3436939 0.87 TYMP (0.45) TYMPMAPK1TK1
SCHEMBL28570790 0.86 TYMP (0.44) TYMPMAPK1TK1
SCHEMBL3364511 0.85 POLB (0.44) TYMPMAPK1TK1
SCHEMBL1452492 0.85 POLB (0.44) TYMPMAPK1TK1
SCHEMBL20473363 0.79 KDM4E (0.41) TYMP
SCHEMBL20541413 0.74 TYMP (0.40) TYMPMAPK1TK1
SCHEMBL3025206 0.74 MAPK1 (0.46) TYMPMAPK1TK1HPGD
SCHEMBL2635616 0.74 MAPK1 (0.42) TYMPMAPK1TK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11938152-B2 High-dose antioxidants in cancer treatment PRASAD KEDAR N (US) 2024-03-26 — — US claimed
US-20220047625-A1 HIGH-DOSE ANTIOXIDANTS IN CANCER TREATMENT PRASAD KEDAR N (US) 2022-02-17 — — US claimed
US-9194802-B2 Luminescent probes having a phenanthridinyl antenna, and methods of use REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2015-11-24 — — US claimed
US-9066866-B2 Direct cellular energy delivery system UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-30 — — US claimed
US-20140329699-A1 SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION OXFORD FINANCE LLC, AS COLLATERAL AGENT 2014-11-06 — — US claimed
EP-2785868-A1 SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION Genapsys Inc. (US) 2014-10-08 — — EP claimed
US-20140080163-A1 LUMINESCENT PROBES HAVING A PHENANTHRIDINYL ANTENNA, AND METHODS OF USE NATIONAL SCIENCE FOUNDATION 2014-03-20 — — US claimed
WO-2013082619-A1 SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION GENAPSYS, INC. (US) 2013-06-06 — — WO claimed
WO-2012166742-A2 SYSTEMS AND METHODS FOR GENETIC AND BIOLOGICAL ANALYSIS GENAPSYS, INC. (US) 2012-12-06 — — WO claimed
WO-2004031393-A1 A BIOSYNTHETIC PROCESS OF TDP-4-KETO-6-DEOXY-D-GLUCOSE AS AN INTERMEDIATE OF DEOXY SUGAR GENECHEM INC. (KR) 2004-04-15 — — WO claimed
CN-122029175-A Modified nucleotide for improving chain offset, preparation method and application thereof 深圳华大智造科技股份有限公司 2026-05-12 — — CN disclosed
US-12297490-B2 Methods for asymmetric DNA library generation and optionally integrated duplex sequencing SOPHIA GENETICS S.A. (CH) 2025-05-13 — — US disclosed
US-20250143359-A1 COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME MARS, INCORPORATED (US) 2025-05-08 — — US disclosed
US-20250127196-A1 COMPOUNDS THAT MODULATE FATTY ACID RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME MARS, INCORPORATED (US) 2025-04-24 — — US disclosed
CN-119790161-A Use of heteroaromatic compounds in nucleic acid detection 深圳华大生命科学研究院 2025-04-08 — — CN disclosed
WO-2012166742-A2 SYSTEMS AND METHODS FOR GENETIC AND BIOLOGICAL ANALYSIS GENAPSYS, INC. (US) 2012-12-06 — — WO disclosed
US-20090148958-A1 NUCLEOTIDE-TRANSITION METAL COMPLEX CATALYST ONECELL INC. 2009-06-11 — — US disclosed
WO-2004031393-A1 A BIOSYNTHETIC PROCESS OF TDP-4-KETO-6-DEOXY-D-GLUCOSE AS AN INTERMEDIATE OF DEOXY SUGAR GENECHEM INC. (KR) 2004-04-15 — — WO disclosed
WO-2004031393-A1 A BIOSYNTHETIC PROCESS OF TDP-4-KETO-6-DEOXY-D-GLUCOSE AS AN INTERMEDIATE OF DEOXY SUGAR GENECHEM INC. (KR) 2004-04-15 — — WO disclosed
WO-1999005160-A2 OLIGONUCLOTIDES HAVING 3' TERMINAL STEREOSPECIFIC PHOSPHOROTHIOATES HYBRIDON, INC. (US) 1999-02-04 — — WO disclosed
Send feedback